1
Study of AZD8931 in Patients With Advanced Solid Malignancies
Condition(s): Advanced Solid Malignancies Last Updated: March 11, 2013Completed
1913 Clinical Trials for: Advanced Solid Malignancies, Page 1 of 96
Hide Studies Not Seeking New Volunteers
2
10mg ZD4054 (Zibotentan) PK Study in Male, Elderly Chinese Patients With Advanced Solid Malignancies
Condition(s): Advanced Solid Malignancies Last Updated: May 18, 2011Completed
3
A Study to Determine the Pharmacokinetics of Cediranib in Chinese Patients With Advanced Solid Malignancies
Condition(s): Advanced Solid Malignancies Last Updated: June 17, 2011Completed
4
Investigate the Safety and Tolerability of Olaparib Tablet in Japanese Patients With Advanced Solid Malignancies
Condition(s): Cancer; Advanced Solid Malignancies Last Updated: April 15, 2013Recruiting
5
Open Label Phase 1 Study in Japan for Patient With Advanced Solid Malignancies
Condition(s): Advanced Solid Malignancy; Advanced Solid Tumor Last Updated: February 4, 2013Recruiting
6
Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours
Condition(s): Cancer; Advanced Solid Malignancies Last Updated: April 10, 2013Recruiting
7
Study to Assess Safety and Tolerability of AZD4547 in Japanese Patient
Condition(s): Cancer; Advanced Solid Malignancies Last Updated: January 8, 2013Active, not recruiting
8
Dose Escalation Study of MLN0128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid Malignancies
Condition(s): Advanced Solid Malignancies; Hematologic Malignancies Last Updated: January 28, 2013Recruiting
9
A Multiple-Ascending-Dose Study of the Safety and Tolerability of REGN421(SAR153192) in Patients With Advanced Solid Malignancies
Condition(s): Advanced Solid Malignancies Last Updated: July 12, 2012Recruiting
10
A Trial to Determine the Maximum Tolerated Dose and Evaluate the Safety and Pharmacokinetics of Docetaxel-PNP, Polymeric Nanoparticle Formulation of Docetaxel, in Subjects With Advanced Solid Malignancies
Condition(s): Advanced Solid Malignancies Last Updated: April 25, 2010Recruiting
11
A Phase I Study of AZD1480 in Patients With Advanced Solid Malignancies and Advanced Hepatocellular Carcinoma in the Escalation Phase,Non-Small Cell Lung Cancer(NSCLC) and Non-smokers With Lung Metastasis and Gastric Cancer and Solid Tumour in the Expansion Phase.
Condition(s): Solid Tumour; Advanced Solid Malignancies; Child-Pugh A to B7 Advanced Hepatocellular Carcinoma; EGFR and/or ROS Mutant NSCLC; Lung Metastasis Carcinoma; Gastric Cancer Last Updated: January 7, 2013Terminated
12
Study of Satraplatin With Capecitabine to Treat Advanced Solid Malignancies
Condition(s): Malignancies Last Updated: March 21, 2012Terminated
13
Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients
Condition(s): Breast Cancer; Hematologic Neoplasms Last Updated: May 10, 2013Completed
14
Open Label, Dose Escalation Phase I Study of AZD2281
Condition(s): Advanced Solid Malignancies Last Updated: August 19, 2009Completed
15
Global Phase1 Study to Assess the Safety and Tolerability of AZD1208 in Advanced Solid Tumors and Malignant Lymphoma
Condition(s): Advanced Solid Malignancies; Malignant Lymphoma Last Updated: August 8, 2012Recruiting
16
A Study of MEDI-575 in Patients With Advanced Solid Malignancies
Condition(s): Advanced Solid Malignancies Last Updated: February 5, 2013Completed
17
Phase I Study of GW572016 With Topotecan to Treat Advanced Solid Malignancies
Condition(s): Advanced Solid Malignancies Last Updated: January 12, 2011Completed
18
A Study of BMS-663513 Administered in Combination With Chemotherapy to Subjects With Advanced Solid Malignancies
Condition(s): Advanced Solid Malignancies Last Updated: September 3, 2009Terminated
19
Absorption, Distribution, Metabolism and Excretion (ADME) Study of TKI258 in Patients With Advanced Solid Malignancies
Condition(s): Advanced Solid Malignancies Last Updated: August 31, 2011Completed
20
Phase1 Study of Gemcitabine HCl Oral Formulation(D07001-F4) in Patients With Advanced Solid Malignancies and Malignant Lymphomas
Condition(s): Advanced Solid Malignancies; Malignant Lymphomas Last Updated: February 25, 2013Not yet recruiting
